Editor for The Biotech Forum, the #2 subscribed to Marketplace investment service offered through SeekingAlpha. Top 5% ranked analyst (TipRanks) 2013 through first half of 2015. Daily contributor for Real Money Pro. Hedge fund manager from 2008 to 2011. Previously technology executive at Fortune 100 firm for a decade.Please go to biotechforumsa.com for more on the Biotech Forum service available through SeekingAlpha. For Free Investment Reports on a variety of topics go to bretjenseninvests.com
Vijar Kohli has a decade of experience in the investment world. He is currently the Portfolio Manager of Golden Door Asset Management (http://www.goldendoorasset.com), a registered investment adviser, specializing in customized separate account management for individuals and businesses. Vijar Kohli founded Golden Door Asset Management L.L.C, in 2013 with Michael Ojo. We have over a decade of professional experience background covers private equity, real estate, investment banking, hedge funds, and wealth management at firms such as J.P. Morgan and Goldman Sachs. As global investors, we analyze companies fundamentally to ensure a margin of safety to identify deep value. Most recently, Vijar worked as a Hedge Fund Relationship Manager at J.P. Morgan's Prime Brokerage Division in New York City. At JPM, he worked in groups such as Sales, Capital Introduction, Risk Management, and Hedge Fund Consulting. He was responsible for managing relationships for a wide variety of hedge funds and has a strong understanding of different investment strategies. Prior to this, he worked in a few bulge bracket firms (Citi, Merrill Lynch). Vijar graduated with honors from Seton Hall University where he earned a B.S. in Finance, with minors in Economics and Accounting. Vijar has a unique knowledge of the international economy, and also studied Healthcare and Economics at Princeton University in New Jersey. Vijar was a member of the New York Society of Security Analysts (NYSSA) and was on the board of Development in Literacy (DIL) in New York. He currently lives in New Jersey and works in New York. Visit his site: Golden Door Asset Management (http://www.goldendoorasset.com/) Visit his blog: CareStocks (http://www.carestocks.com/)
The Insiders Forum is brought to you by Bret Jensen, one of SeekingAlpha's most followed contributors and author of The Biotech Forum which is is the second most subscribed to service of the over 60 available via the MarketPlace.
Insiders Forum will be strictly focused on small and mid-cap stocks that insiders are buying. Some studies have shown that equities with heavy insider purchases outperform the overall market over time. The Insiders Forum will consist of my 15 top small and mid-sized stocks in different sectors of the market that are not only are attractively valued but have had some significant insider purchases in recent months.
We will build out an optimized 15 stock portfolio one stock at a time and track performance using a hypothetical $150,000 portfolio. The Insider Forum will feature bi-weekly portfolio updates as well as least one exclusive article a week on stocks with recent insider buying. Deep and exclusive analysis will be provided on all new additions to the portfolio. Our goal will be to outperform the Russell 2000 over time and the Insiders Forum's portfolio will be benchmarked against.
Our goal is to outperform the Russell 2000 over time as well as to be a sounding board for new investments in attractively priced equities where insiders are stepping up to the plate.
We put a lot of work into our articles on Seeking Alpha, but our best investment ideas are exclusively available at BlueHarbinger.com. Blue Harbinger is an independent investment research and consulting company headquartered in Naperville, IL. Our mission is to help you identify exceptional investment opportunities while avoiding the high costs and conflicts of interest that are prevalent throughout the industry.
Blue Harbinger was founded by Mark D. Hines after a 15-year career in the financial services industry. Hines previously managed an $11 billion equity investment program at Wespath Investment Management, and also was a portfolio manager on the active equities team at Northern Trust Global Investments. Mr. Hines holds a BS in Finance from the University of Illinois at Urbana-Champaign, and an MBA from the University of Chicago. If you're ever in the Naperville area, he is happy to meet you at a local coffeehouse to talk about investments. Please feel free to get in touch.
Frances Coppola worked in banking for 17 years as a business analyst and project manager, running business and systems projects for (among others) RBS, Nat West, HSBC, Midland Bank and SBC Warburg (now UBS). Her banking experience encompasses retail and investment banking, front office, operations and settlement, but her particular area of expertise is financial control and risk management. She is particularly proud of the fact that RBS still produces its financial and regulatory reporting using a group consolidation system that she designed.
Frances is now a writer and commentator on banking, finance and economics. Her blog Coppola Comment is widely read and her writing has featured on the Financial Times, City AM, The Economist. The Guardian and a range of online publications. She also writes for the online magazine Pieria and occasionally for the ICAEW, and she is a frequent commentator on banking matters for the BBC.
Frances has an MBA from Cass Business School with a specialism in finance and risk management. And since financial people can be creative too, Frances is also a professional singer and singing teacher. She has a B.Mus from London University and is an Associate of the Royal College of Music. She also has two teenage children and not much time to do the garden any more!
Chris (email@example.com) is an Hon B.Sc graduate (with distinction) in Science and Economics with over 15 years in investing experience. He holds a PMP (Project Management Professional) designation. TipRanks Top 100 Blogger of 2015 (also 2013, 2014). Seeks undervalued, unappreciated value stock ideas. Follows Warren Buffet's mantra: do not lose money. For a better mobile experience on Seeking Alpha click on the top right menu icon on most browsers and select "request desktop site".
Over 30 years of investing in individual stocks. Extensive business experience with small to mid-size companies, including as CEO. Many hundreds of blog posts on financial and economic matters since 2008. Focus on value with catalysts for upside price action. Background as a physician and pharmaceutical inventor and entrepreneur, however focus now is global and involves almost all economic categories.
My name is Dr Kanak Kanti De, MBBS, MD, PhD, retired medical practitioner, cancer survivor, healthcare sector investor, over 30 years' experience in the sector both in India and the United States. I write/have written on Motley Fool, SeekingAlpha, Benzinga, and on Forbes. I am consistently ranked high on TipRanks, although I don't like their ranking system. My portfolio has consistently beat the various indices for years. Email me to discuss my articles, or for just an adda (Bengali for informal chat) firstname.lastname@example.org.
CFA Charterholder and capital markets enthusiast looking for opportunities which go against consensus while hedging exposure. I believe good ideas take time to develop and it's important to be compensated while waiting for your investment thesis to play out.
I am a psychologist at the University of Massachusetts/Amherst. I am on our campus’s Institutional Review Board, which must conclude that proposed studies involving human subjects are conducted ethically and are designed well enough so that any risks involved are justified by the likely benefits obtained.
I teach about analytical reasoning, leadership skills, reconciling apparently incompatible positions, designing, implementing, and evaluating policies, and how to critically evaluate competing health claims based on the samples studied and methods of data collection and analysis used.
Most of my investments involve owning medical industry stocks.
Jeff is the President of NewArc Investments Inc., manager of both individual and institutional investments. Jeff is a registered investment advisor, and portfolio manager for NewArc's investment programs.
Jeff is a former college professor with a hands-on, real world attitude. His quantitative modeling helped inform state and local officials in Wisconsin for more than a decade. A Public Policy analyst, he taught advanced research methods at the University of Wisconsin, and analyzed many issues related to state tax policy.
Jeff began in the financial business as Research Director for trading firm at the Chicago Board Options Exchange. He investigated anomalies in the standard option pricing models, taught classes for beginning options traders, and developed new forecasting techniques. In 1991 he established a general research consultancy, working with professional traders at all of the Chicago financial exchanges. In 1998 he started NewArc Investments, Inc.
Jeff has a commitment to the specific needs of individual investors. It is not a one-size-fits all approach, but one that emphasizes the unique circumstances of each client.
Jeff also serves on the board of two small technology companies (currently Chairman at one). He is occasionally as an expert witness in legal cases involving financial markets and hedging.
Surgeon with a highly varied background. Mixture of buy and hold equities and higher risk securities and LEAP calls.
The picture is James K. Polk; one of our most successful and underrated presidents. Ran for office stating he would accomplish 4 things. Accomplished all four, died shortly after his term completely exhausted.
Mr. Berger is the creator and developer of the YDP screening tool, a chart system and its analysis for screening and monitoring dividend income equity investments. The recipient of Seeking Alpha's Outstanding Performance Award, he also has been Seeking Alpha's #3 ranked Author for Income Investing Strategy & #4 for Utilities.
20 years of sitting in the board room gives me unique insights into Oil & Gas investments and corporate deal making in general. Additionally, he offers a Premium Research subscription service for boosting income while reducing market risk using covered option writing on a dividend income equity portfolio.
Residing in Brazil gives me a local's inside view on the pulse of its economy, politics, investment climate and breaking news. A view of my front yard is available here.
A former Chief Operating Officer, Director, Vice President and General Manger of Oil and Gas for Southern Pacific's Oil and Gas Operations, Business owner, geologist, and cribbage player, I've been an investor for over 48 years (started young at 13) and learned my lessons the way that makes them stick, by hard knocks and both big and little mistakes. Hopefully I can share some of those lessons with others.
I am an American expatriate that decided to retire at age 57 in 2009 and now live in Brazil. As an early retiree I invest for income and manage portfolio risk by screening for strong and reliable historic data along with favorable fundamental and technical current trends.
I spend 6 months/year living at home in Brazil and 6 months/year traveling the world. I have structured my financial positions so that I live virtually tax free with much of my income exempt from US tax since I live ex patriot and a lot of my US derived income over the annual ex-patriate exemptions is held in my tax free ROTH and tax deferred IRA/SIMPLE plans. This enables my tax savings to pay for my 6 months of annual traveling :) .
My investing is for income and appreciation with a balance of low to moderate short term risk and low long term risk. To accomplish this I use quality dividend payors with a long track record of steady or increasing dividends along with slowly appreciating equity prices. I target a 6 to 9 % yield and almost exclusively require a minimum history of 5 years of steady/increasing dividends and no decreases in dividend ever or at least past 10 years. I diversify through sector, country and currency unit the stocks are traded in, and security type (equity, royalty trust, REIT, mlp, etf, and ADRs).
I use covered call writing to enhance my portfolio yield with no added risk. In fact, it lowers the risk substantially. Once I identify a stock I want to own and an entry price for it, I write cash covered puts at or below that entry price (with a minimum of 1%/month time premium. Thus i obtain at least a 12% annualized yield before compounding just from the option premium.
Likewise, I use the sale of cash covered puts to generate income and and generally get an entry point at 5 to 10% below my acceptable entry level price if/when the put stock does get presented. Thus my strategy provides a 12% pre compound yield on cash and entry into stock purchases at a 5 to 10% discount from "retail".
Because I only select stocks that I am willing to hold long term for their reliable dividend yields of > 6%, I am not concerned much with market volatility or short/midterm risk. Indeed, market volatility is my friend since it increases the premiums paid on the options I sell. I also selectively sell covered calls on positions I hold long so as to add to my yield that way while not taking on any additional risk.
This strategy has kept me happily living off my portfolio income and traveling 1/2 the year while my portfolio has been slowly increasing in value even after my harvesting income for living expenses. Of course my income will incrementally increase when social security kicks in for me in a few more years and I may then slightly mofidy my goals and strategies.
Readers can get an e-mail once a day from Seeking Alpha that lists all newly published articles of ALL the authors they follow in a single e-mail. To get these updates:
- a - Click "Alerts" along the top menu tab (just left of the green PRO tab)
- b - Scroll all the way down, and check the box for "author alerts" (2nd box from the bottom)
- c - Then you'll be notified by Seeking Alpha once per day of new articles by all authors you follow (in a single e-mail)
Biophile6 is an award winning small business person, chemist, biochemist, and microbiologist (Emory - Ph.D.; Harvard - Post Doc) with professional interest in clinical informatics, small business management, biotech valuation,and drug development. A former prep school chemistry instructor and cross country runner/skier, his professional goal is to organize the complex disciplines of drug compound identification and target validation, especially as regards bacterial and viral pathogens, for the purposes of clinical infection control, microbial pathogen surveillance, diagnostics, and vaccine development. Side interests include small business management, biofuels, metabolic pathway design, natural products chemistry, thorium nuclear, material coatings, metals and mining. He designs informatics algorithms, with an eye to devise new principles upon which to order research information meaningfully.
These same principles of the evolution of life can drive the evolution of companies.
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
Jonathan Moreland is the founder and Director of Research at InsiderInsights.com, which produces the weekly InsiderInsights Newsletter, and offers institutional strength, real-time insider data and analytics via a subscription Data Module and APIs. He is also principal of Insider Asset Management llc, a registered investment advisor in New York State, and a past contributor to TheStreet.com, Minyanville, and other financial outlets.
A fundamental analyst with an MBA in finance, Mr. Moreland identified insider data over 25 years ago as an excellent first screen to determine where to focus his research efforts. He is quoted frequently in the media for his insider analysis, and stock recommendations stemming from it. He is also author of Profit From Legal Insider Trading (Dearborn 2001), and has a new book due out with Wiley.
Mr. Moreland is currently on a mission to get investors to expect more from insider data than the commodity feeds they rely on from their Bloomberg terminals, Yahoo!Finance, and other financial websites.
INDEPENDENT Financial Advisor / Professional Investor- with over 30 years of navigating the Stock market's "fear and greed" cycles that challenge the average investor. Investment strategies that combine Theory, Practice and Experience to produce Portfolios focused on achieving positive returns over a period of time. Providing advice in helping to avoid the pitfalls and traps that wreak havoc on your portfolio with a focus on Income and Capital Preservation.
I manage the capital of only a handful of families and I see it as my number one job to protect their financial security. They don’t pay me to sell them investment products, beat an index, abandon true investing for mindless diversification or follow the Wall Street lemmings down the primrose path. I manage their money exactly as I manage my own so I don’t take any risk at all unless I strongly believe it is worth taking.
Blogging here on SA is part of my research. I write to find out what I think.
I invite you to join the family of satisfied clients send an e-mail :email@example.com
Have retired after having an over 20 year successful career as a Senior Financial Analyst for a Fortune 500 company where I performed due diligence on acquisitions, potential acquisitions as well as contributed to the completion of annual reports and preparing materials for the investment community. I am a bit rusty but I realized over the last 7 years that my analytical skills and niche in the the healthcare industry, specifically Biotechs, lends quite naturally to trading and covered calls. I am generally long, but the point of this business is to make money so I have developed my own method to take profits. Most recently I hold positions in $COR, $MAIN, $EXEL, $LXRX, $AKAO, $DYAX, $DVAX, $,GILD, $CELG, $LGND, $XON, $IRMD, $MITK, $ATVI, $AFFX, $TEVA,$PACB, $BPMC, $RLYP, $EGRX, $THLD, $ADXS, $O, $MITT,$T, $VZ, $VTR, $LMAT, $MO& $ED, $AAPL, $AMBA, $CRTO, $KR, $NKE, $DFS $SBUX just to name a few. I have been a consultant and consumer in the healthcare/biotech market for years and have been able to seek out growth opportunities and likely and successful buyout candidates with 15% of my portfolio dedicated to late-stage biotech specs and have achieved tremendous success, most recent examples are $SURG & $AFFX. Overall, however I do maintain a diversified portfolio and choose dividend paying stocks that offer both growth and income, specifically $MO, $TEVA, $BOH, $SBUX, $T, $HBI, were purchased during corrections providing outstanding yield & growth. I do utilize options very selectively to generate additional income, a strategy I that I find too risky during such volatility as we have experienced since the summer of 2015 through the drop we are currently experiencing currently. I am always re-evaluating my holdings, taking some profits, allowing for a larger cash position and taking advantage of the low prices of quality stocks. Biotech's seem to have been hit the hardest during these rotational corrections however if well researched, there is an excellent reward /risk profile and there is money to be made as long as spec investments are kept within your budget & there is a realistic understanding of the potential to lose it all. I both make and advise buys, as best as I can, to protect against the increased global instability & volatility this market is experiencing, regardless of the industry or company, that no one is immune from large losses so I don't invest what I can't afford to lose. Having had more than a few sleepless nights over the last 6-8 mos. in particular, my motto is if it keeps you up at night, rebalance!. I am always open to here other contributors' views whether or not they match my own, I believe we all have the ability to learn something valuable form each other.
Seeking Alpha's business development team is responsible for relationships with partner websites, investment and trading platforms for professional and retail users and major media companies. The purpose of this profile is to allow us to share details of new partnerships and updates on longstanding relationships. Guy Cohen - Director of Business Development: firstname.lastname@example.org Adam Jackson - Director of Content Partnerships: email@example.com Rachael Granby - Director of Product Development & Enhancement: firstname.lastname@example.org
Managing personal and family funds since 1971. Curiosity is the first step to profitability. Constantly researching opportunities. Retired at age 51 then married my long time sweetheart at age 58. Trade daily, rarely short individual stock but will hedge using inverse 2x ETFs/ETNs.
B.A. M.P.A. J.D Phi Kappa Phi
I am Spanish but I have lived for many years in UK, France and the Isle of Man. I follow very closely the Spanish and European markets although I buy and hold stocks from all over the world. I started investing in 1999 and I have survived the dotcom and the financial crises... I am planning to retire soon to "work" as a full time investor. I also help other people with their investments. In previous live I have been and auditor in one of the bigfour and Finance Director of large multinationals, which helps me understanding the Balance Sheets and P&Ls (Income Statements) of the companies I invest in. Usually long term investor with a Value based approach.
I've been retired for about 5 years as a fishery/habitat biologist in Alaska and am still living here. Since retirement I have been attempting to improve my dividend stock-oriented portfolios in my retirement accounts.